Lombard Odier Asset Management (Europe)’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-44,663
| Closed | -$2M | – | 160 |
|
|
2024
Q4 | $2M | Hold |
44,663
| – | – | 0.13% | 157 |
|
|
2024
Q3 | $2.81M | Buy |
44,663
+14,564
| +48% | +$850K | 0.12% | 196 |
|
|
2024
Q2 | $1.78M | Buy |
30,099
+6,927
| +30% | +$433K | 0.08% | 208 |
|
|
2024
Q1 | $1.85M | Sell |
23,172
-31
| -0.1% | -$2.37K | 0.11% | 162 |
|
|
2023
Q4 | $1.83M | Buy |
23,203
+2,780
| +14% | +$198K | 0.11% | 165 |
|
|
2023
Q3 | $1.43M | Sell |
20,423
-51
| -0.2% | -$3.61K | 0.07% | 205 |
|
|
2023
Q2 | $1.42M | Sell |
20,474
-1,178
| -5% | -$83.8K | 0.07% | 209 |
|
|
2023
Q1 | $1.61M | Buy |
21,652
+12,708
| +142% | +$1.07M | 0.08% | 207 |
|
|
2022
Q4 | $833K | Sell |
8,944
-6,901
| -44% | -$666K | 0.03% | 245 |
|
|
2022
Q3 | $1.51M | Sell |
15,845
-889
| -5% | -$88K | 0.08% | 196 |
|
|
2022
Q2 | $1.55M | Buy |
16,734
+5,551
| +50% | +$542K | 0.08% | 191 |
|
|
2022
Q1 | $1.13M | Buy |
11,183
+1,838
| +20% | +$193K | 0.04% | 164 |
|
|
2021
Q4 | $964K | Buy |
+9,345
| New | +$864K | 0.04% | 157 |
|
|
2021
Q1 | – | Sell |
-12,132
| Closed | -$822K | – | 263 |
|
|
2020
Q4 | $822K | Buy |
12,132
+476
| +4% | +$31K | 0.05% | 151 |
|
|
2020
Q3 | $681K | Hold |
11,656
| – | – | 0.04% | 146 |
|
|
2020
Q2 | $757K | Hold |
11,656
| – | – | 0.11% | 102 |
|
|
2020
Q1 | $692K | Sell |
11,656
-1,839
| -14% | -$123K | 0.06% | 138 |
|
|
2019
Q4 | $1M | Hold |
13,495
| – | – | 0.07% | 121 |
|
|
2019
Q3 | $851K | Hold |
13,495
| – | – | 0.07% | 132 |
|
|
2019
Q2 | $735K | Hold |
13,495
| – | – | 0.06% | 144 |
|
|
2019
Q1 | $728K | Buy |
13,495
+461
| +4% | +$28.5K | 0.07% | 130 |
|
|
2018
Q4 | $854K | Buy |
13,034
+2,773
| +27% | +$207K | 0.08% | 128 |
|
|
2018
Q3 | $808K | Hold |
10,261
| – | – | 0.06% | 147 |
|
|
2018
Q2 | $660K | Hold |
10,261
| – | – | 0.05% | 152 |
|
|
2018
Q1 | $638K | Sell |
10,261
-1,282
| -11% | -$92K | 0.04% | 158 |
|
|
2017
Q4 | $837K | Sell |
11,543
-673
| -6% | -$48.9K | 0.05% | 147 |
|
|
2017
Q3 | $993K | Hold |
12,216
| – | – | 0.06% | 131 |
|
|
2017
Q2 | $983K | Hold |
12,216
| – | – | 0.06% | 123 |
|
|
2017
Q1 | $959K | Sell |
12,216
-2,910
| -19% | -$232K | 0.05% | 116 |
|
|
2016
Q4 | $1.19M | Hold |
15,126
| – | – | 0.43% | 55 |
|
|
2016
Q3 | $1.35M | Hold |
15,126
| – | – | 0.46% | 54 |
|
|
2016
Q2 | $1.45M | Buy |
+15,126
| New | +$1.51M | 0.08% | 84 |
|
Other funds holding CVS
Lombard Odier Asset Management (Europe)'s CVS Position: Q1 2025 in Review
Lombard Odier Asset Management (Europe) sold out of CVS Health (CVS) in Q1 2025, closing a stake of 44,663 shares — an estimated $2M sold.
Lombard Odier Asset Management (Europe) first reported a position in CVS in Q2 2016 and held it in 32 quarters. The position peaked at $2.81M in Q3 2024. 1,754 funds tracked by Wall St. Rank hold CVS as of Q1 2025.
- Lombard Odier Asset Management (Europe) reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
- Lombard Odier Asset Management (Europe) sold 44,663 CVS Health shares in Q1 2025, an estimated $2M.
- Lombard Odier Asset Management (Europe) first reported a position in CVS Health in Q2 2016 and held it in 32 quarters.
- Lombard Odier Asset Management (Europe)'s CVS Health position peaked at $2.81M in Q3 2024.
- 1,754 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.
Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q1 2025, filed 15 May 2025.